Covid XBB Variant: Study of 42 XBB.1.16 patients finds 11 had taken 3rd dose | Pune News - Times of India
Covid19-Sources
Is there a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?
An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial
Real time analysis of SARS-CoV-2 induced cytolysis reveals distinct variant-specific replication profiles
Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England
Long-term cardiovascular outcomes of COVID-19
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
The Effects of COVID-19 on the Placenta During Pregnancy
Pfizer-pharmacokinetics-and-toxicity.pdf | Powered by Box
Immungedächtnis nach SARS-CoV-2: Eine COVID-Infektion schützt mindestens so gut wie die Impfung
Effectiveness of HEPA Filters at Removing Infectious SARS-CoV-2 from the Air - PubMed
Niedrige Vitamin-D-Spiegel bei Patienten mit Post-COVID-Syndrom
Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis
4. ConclusionsThe current evidence supports the benefits of vitamin D interventions in patients hospitalized with COVID-19 due to the protective effect provided by vitamin D against ICU admission and mortality. A meta-analysis per se does not allow us to state whether the results are truly positive or false-positive. In addition, the inclusion of studies with large effect sizes and significant heterogeneity separates us from the truth. For this reason, a TSA is mandatory to verify the reliability of meta-analysis results [92]. In conclusion, the positive results highlighted again and now validated by TSAs suggest that an indisputable association between vitamin D supplementation and the protective effect on ICU admission can be considered definitive evidence. On the contrary, further studies are needed to assess the utilization of vitamin D regarding the risk of death in patients hospitalized with COVID-19.
Expectations and Prior Experiences Associated With Adverse Effects of COVID-19 Vaccination
AOK-Analyse: Höchster Krankenstand seit Beginn der Aufzeichnungen 1991
Ergänzende Behandlung mit Curcumin, Quercetin und Vitamin D bei mildem/moderatem COVID-19 • DGP
Statement on 'Physical interventions to interrupt or reduce the spread of respiratory viruses' review
The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study
Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people, England - Office for National Statistics
The potential impacts of obesity on COVID-19
Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells - Clinical Epigenetics
CO2 Masks
Abwasserscreening auf Coronaviren
Differences in SARS-CoV-2 Specific Humoral and Cellular Immune Responses after Contralateral and Ipsilateral COVID-19 Vaccination
COVID-19 and Occupational Impacts
Forecasting the trajectory of the COVID-19 pandemic into 2023 under plausible variant and intervention scenarios: a global modelling study
Functional Neurological Disorder Emerges After COVID Infection, Vaccines
In unvaccinated pregnant women, Covid can cause deadly harm to babies
Multiomic characterisation of the long-term sequelae of SARS survivors: a clinical observational study